Emma Hume

May 23, 2024 | jamanetwork.com | Jessica Y. Islam |Cassandra A. Hathaway |Emma Hume |Julie Hallanger-Johnson

Characteristics of Patients With Cancer and COVID-19 Who Discontinued Cancer Treatment Introduction The COVID-19 pandemic disrupted access to cancer treatment.1 COVID-19–related disruptions in treatment may have disproportionately affected individuals who experienced a high burden of COVID-19–related disease.1 Our objective was to evaluate cancer treatment discontinuations (TDs) among patients with cancer who received a diagnosis of SARS-CoV-2 during their cancer treatment planning. Methods...

May 20, 2024 | jamanetwork.com | Jessica Y. Islam |Cassandra A. Hathaway |Julie Hallanger-Johnson |Emma Hume

Key PointsQuestion  Among patients with cancer and a confirmed SARS-CoV-2 infection identified during their cancer treatment planning, were there racial and ethnic differences in cancer treatment continuity throughout different waves of the COVID-19 pandemic?